Q3 2024 |
192 |
$7.68B |
+$1.08B |
-$364M |
+$720M |
AVGO, T, C, CME, PFE
|
13F-HR |
11/8/2024, 05:55 PM |
Q2 2024 |
189 |
$7.11B |
+$517M |
-$619M |
-$103M |
AVGO, T, C, PFE, CME
|
13F-HR |
8/7/2024, 06:37 PM |
Q1 2024 |
187 |
$7.17B |
+$404M |
-$966M |
-$562M |
AVGO, C, T, JPM, CME
|
13F-HR |
5/13/2024, 04:58 PM |
Q4 2023 |
196 |
$6.93B |
+$647M |
-$470M |
+$178M |
AVGO, C, CME, T, JPM
|
13F-HR |
2/8/2024, 11:15 AM |
Q3 2023 |
196 |
$6.08B |
+$492M |
-$445M |
+$47.7M |
AVGO, CME, PFE, JPM, C
|
13F-HR |
11/13/2023, 10:38 AM |
Q2 2023 |
184 |
$6.17B |
+$433M |
-$597M |
-$165M |
AVGO, CME, PFE, JPM, QCOM
|
13F-HR |
8/8/2023, 04:04 PM |
Q1 2023 |
185 |
$6.05B |
+$327M |
-$468M |
-$141M |
AVGO, CME, PFE, JPM, QCOM
|
13F-HR |
5/9/2023, 01:01 PM |
Q4 2022 |
201 |
$5.91B |
+$254M |
-$596M |
-$341M |
PFE, AVGO, CME, JPM, RF
|
13F-HR |
2/7/2023, 06:23 PM |
Q3 2022 |
200 |
$5.65B |
+$410M |
-$691M |
-$282M |
CME, PFE, AVGO, RF, QCOM
|
13F-HR |
11/14/2022, 05:59 PM |
Q2 2022 |
201 |
$6.53B |
+$669M |
-$608M |
+$60.4M |
CME, ABBV, AVGO, PFE, QCOM
|
13F-HR |
8/5/2022, 02:04 PM |
Q1 2022 |
196 |
$7.63B |
+$411M |
-$766M |
-$355M |
CME, AVGO, ABBV, PFE, QCOM
|
13F-HR |
5/11/2022, 06:23 PM |
Q4 2021 |
208 |
$8.53B |
+$803M |
-$1.04B |
-$239M |
AVGO, CME, ABBV, QCOM, PFE
|
13F-HR |
2/10/2022, 05:22 PM |
Q3 2021 |
209 |
$8.15B |
+$707M |
-$984M |
-$277M |
CME, AVGO, ABBV, JPM, HD
|
13F-HR |
11/9/2021, 06:23 PM |
Q2 2021 |
1 |
$9.01M |
$0 |
$0 |
|
GTES
|
New Holdings |
10/12/2021, 04:08 PM |
Q2 2021 |
206 |
$8.7B |
+$676M |
-$859M |
-$183M |
CME, JPM, ABBV, AVGO, CIM
|
13F-HR |
8/10/2021, 06:55 PM |
Q1 2021 |
207 |
$8.62B |
+$719M |
-$1.09B |
-$372M |
JPM, CME, ABBV, AVGO, BABA
|
13F-HR |
5/14/2021, 03:38 PM |
Q4 2020 |
227 |
$8.43B |
+$1.71B |
-$2.12B |
-$408M |
CME, JPM, AVGO, ABBV, BABA
|
13F-HR |
2/9/2021, 01:51 PM |
Q3 2020 |
164 |
$7.56B |
+$343M |
-$957M |
-$614M |
BABA, JPM, CME, ABBV, HD
|
13F-HR |
11/5/2020, 01:06 PM |
Q2 2020 |
159 |
$7.79B |
+$800M |
-$1.39B |
-$587M |
ABBV, BABA, JPM, CME, HD
|
13F-HR |
8/7/2020, 02:17 PM |
Q1 2020 |
163 |
$6.99B |
+$697M |
-$1.44B |
-$747M |
BABA, CME, JPM, WBA, RDSA
|
13F-HR |
5/13/2020, 01:43 PM |
Q4 2019 |
171 |
$10.4B |
+$500M |
-$1.4B |
-$903M |
CME, JPM, RDSA, BABA, QCOM
|
13F-HR |
2/7/2020, 06:05 PM |
Q3 2019 |
170 |
$10.4B |
+$576M |
-$751M |
-$175M |
CME, JPM, RDSA, BABA, HD
|
13F-HR |
11/12/2019, 01:20 PM |
Q2 2019 |
170 |
$10.4B |
+$723M |
-$1.02B |
-$297M |
CME, RDSA, JPM, BABA, QCOM
|
13F-HR |
8/6/2019, 12:04 PM |
Q1 2019 |
175 |
$10.3B |
+$640M |
-$1.51B |
-$868M |
RDSA, CME, JPM, BABA, WBA
|
13F-HR |
5/7/2019, 04:00 PM |
Q4 2018 |
171 |
$10.2B |
+$766M |
-$901M |
-$134M |
CME, RDSA, JPM, WBA, QCOM
|
13F-HR |
2/6/2019, 04:00 PM |
Q3 2018 |
161 |
$12B |
+$811M |
-$2.29B |
-$1.48B |
RDSA, CME, JPM, WBA, QCOM
|
13F-HR |
11/2/2018, 10:58 AM |
Q2 2018 |
227 |
$13.2B |
+$1.06B |
-$1.47B |
-$404M |
RDSA, CME, JPM, WBA, HD
|
13F-HR |
8/14/2018, 10:38 AM |
Q1 2018 |
231 |
$13.3B |
+$1.27B |
-$2.07B |
-$801M |
RDSA, CME, JPM, WBA, HD
|
13F-HR |
5/7/2018, 10:43 AM |
Q4 2017 |
243 |
$14.4B |
+$1.22B |
-$1.27B |
-$51.8M |
JPM, CME, RDSA, HD, QCOM
|
13F-HR |
2/14/2018, 10:17 AM |
Q3 2017 |
243 |
$14B |
+$1.91B |
-$1.48B |
+$427M |
JPM, CME, RDSA, HD, MRK
|
13F-HR |
11/13/2017, 09:59 AM |
Q2 2017 |
249 |
$13.1B |
+$1.75B |
-$1.47B |
+$284M |
JPM, CME, RDSA, HD, MRK
|
13F-HR |
8/14/2017, 10:22 AM |
Q1 2017 |
265 |
$12.3B |
+$1.47B |
-$2.83B |
-$1.35B |
JPM, CME, RDSA, HD, WBA
|
13F-HR |
5/9/2017, 10:36 AM |
Q4 2016 |
273 |
$13B |
+$1.39B |
-$1.82B |
-$431M |
JPM, CME, RDSA, HD, WBA
|
13F-HR |
2/10/2017, 01:48 PM |
Q3 2016 |
254 |
$13.1B |
+$1.21B |
-$1.69B |
-$482M |
JPM, CME, RDSA, AGN, HD
|
13F-HR |
11/14/2016, 09:27 AM |
Q2 2016 |
260 |
$12.9B |
+$1.35B |
-$3.48B |
-$2.13B |
JPM, RDSA, CME, AGN, HD
|
13F-HR |
8/12/2016, 12:05 PM |
Q1 2016 |
264 |
$15B |
+$2.12B |
-$2.97B |
-$853M |
JPM, CME, HD, T, C
|
13F-HR |
5/12/2016, 10:58 AM |
Q4 2015 |
292 |
$15.7B |
+$1.61B |
-$2.04B |
-$432M |
CME, JPM, HD, T, RDSA
|
13F-HR |
2/9/2016, 11:57 AM |
Q3 2015 |
275 |
$15.9B |
+$3.2B |
-$2.88B |
+$320M |
CME, JPM, HD, T, AGN
|
13F-HR |
11/12/2015, 10:17 AM |
Q2 2015 |
306 |
$17.4B |
+$3.61B |
-$4.5B |
-$891M |
CME, JPM, RDSA, HD, LBTYK
|
13F-HR |
8/12/2015, 09:25 AM |
Q1 2015 |
306 |
$18B |
+$2.49B |
-$4.57B |
-$2.08B |
JPM, CME, RDSA, NXPI, LBTYK
|
13F-HR |
5/13/2015, 11:53 AM |
Q4 2014 |
303 |
$20B |
+$2.74B |
-$5.32B |
-$2.58B |
JPM, RDSA, LBTYK, BIDU, BABA
|
13F-HR |
2/11/2015, 11:04 AM |
Q3 2014 |
312 |
$22.2B |
+$2.5B |
-$4.96B |
-$2.46B |
JPM, BIDU, B108PS, LBTYK, SLB
|
13F-HR |
11/12/2014, 10:07 AM |
Q2 2014 |
319 |
$25.1B |
+$4.35B |
-$5.22B |
-$871M |
SLB, BIDU, TSM, JPM, ACN
|
Restatement |
8/11/2014, 02:35 PM |
Q1 2014 |
292 |
$25.4B |
+$4.29B |
-$4.05B |
+$243M |
SLB, BIDU, YUM, ACN, BBVA
|
13F-HR |
5/14/2014, 04:41 PM |
Q4 2013 |
284 |
$26.2B |
$0 |
$0 |
|
BIDU, SLB, YUM, YNDX, LBTYA
|
13F-HR |
2/13/2014, 01:57 PM |